Literature DB >> 30415068

Alterations of hippocampal neurogenesis during development of Alzheimer's disease-like pathology in OXYS rats.

Ekaterina A Rudnitskaya1, Tatiana A Kozlova2, Alena O Burnyasheva2, Natalyia G Kolosova2, Natalia A Stefanova2.   

Abstract

Neurogenesis is the key mechanism of neuronal plasticity in the adult mammalian brain. Alterations of neurogenesis happen concurrently with (and contribute to) development and progression of numerous neuropathological conditions including Alzheimer's disease (AD). Being the most common type of dementia, AD is studied extensively; however, the data concerning changes in neurogenesis in the pathogenesis of this disease are inconsistent. Here, using OXYS rats as a suitable model of the most common (sporadic) form of AD, we examined neurogenesis in the hippocampal dentate gyrus in early ontogenesis prior to appearance of any signs of neurodegeneration and during development and progression of AD-like pathology. We demonstrated retardation of hippocampal development in OXYS rats at an early age; this problem may contribute to the emergence of AD signs late in life. Manifestation and progression of AD-like pathology are accompanied by transcriptome changes affecting genes involved in neurogenesis in the hippocampus. These genes are associated with the extracellular matrix and angiogenesis; this observation points to alteration of a cellular microenvironment. This change along with an increased TrkA/p75NTR ratio of nerve growth factor receptors in the hippocampus may contribute to increased density of immature neurons that we observed at the progressive stage of AD-like pathology in OXYS rats. These changes may be considered a compensatory reaction intended to slow down AD-associated neurodegeneration at the progressive stage of the disease. Collectively, these data suggest that alterations of neurogenesis may not only accompany the course of Alzheimer's disease but also play a causative role in this disorder.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adult neurogenesis; Alzheimer's disease; Hippocampus; OXYS rats; RNA sequencing

Mesh:

Substances:

Year:  2018        PMID: 30415068     DOI: 10.1016/j.exger.2018.11.008

Source DB:  PubMed          Journal:  Exp Gerontol        ISSN: 0531-5565            Impact factor:   4.032


  5 in total

1.  Alterations of STEP46 and STEP61 Expression in the Rat Retina with Age and AMD-Like Retinopathy Development.

Authors:  Darya V Telegina; Elizabeth A Kulikova; Oyuna S Kozhevnikova; Alexander V Kulikov; Tatyana M Khomenko; Konstantin P Volcho; Nariman F Salakhutdinov; Nataliya G Kolosova
Journal:  Int J Mol Sci       Date:  2020-07-22       Impact factor: 5.923

2.  Changes in Glial Support of the Hippocampus during the Development of an Alzheimer's Disease-like Pathology and Their Correction by Mitochondria-Targeted Antioxidant SkQ1.

Authors:  Ekaterina A Rudnitskaya; Alena O Burnyasheva; Tatiana A Kozlova; Daniil A Peunov; Nataliya G Kolosova; Natalia A Stefanova
Journal:  Int J Mol Sci       Date:  2022-01-20       Impact factor: 5.923

3.  Intracranial alternating current stimulation facilitates neurogenesis in a mouse model of Alzheimer's disease.

Authors:  Qian Liu; Yihang Jiao; Weijian Yang; Beiyao Gao; Daniel K Hsu; Jan Nolta; Michael Russell; Bruce Lyeth; Theodore P Zanto; Min Zhao
Journal:  Alzheimers Res Ther       Date:  2020-07-23       Impact factor: 8.823

4.  Mechanisms of Neuronal Death in the Cerebral Cortex during Aging and Development of Alzheimer's Disease-Like Pathology in Rats.

Authors:  Darya V Telegina; Gleb K Suvorov; Oyuna S Kozhevnikova; Nataliya G Kolosova
Journal:  Int J Mol Sci       Date:  2019-11-11       Impact factor: 5.923

5.  Cognitive Training as a Potential Activator of Hippocampal Neurogenesis in the Rat Model of Sporadic Alzheimer's Disease.

Authors:  Alena O Burnyasheva; Tatiana A Kozlova; Natalia A Stefanova; Nataliya G Kolosova; Ekaterina A Rudnitskaya
Journal:  Int J Mol Sci       Date:  2020-09-23       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.